Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients.

Journal of psychopharmacology (Oxford, England) - 1 Sept 2007

Bozina Nada, Medved Vesna, Kuzman Martina Rojnic, Sain Ivica, Sertic Jadranka

Abstract excerpt

We investigated the relationships between L/S promoter (SERTPR) and l/s intron2 (SERTin2) genetic variants of serotonin transporter (SERT) polymorphisms with olanzapine-induced weight gain and treatment response in 94 female schizophrenic patients treated with olanzapine for up to 3 months. Body...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Benzodiazepines
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Croatia

Share to Olanzapine

Share to Psychiatric Status Rating Scales

Share to Serotonin Plasma Membrane Transport Proteins

Share to Weight Gain

Source

Identifiers

PMID: 17092963
DOI: 10.1177/0269881106072750

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17092963-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients.PMID 17092963Read ↗

-759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia.Semantic proximity Read ↗

A pharmacogenomic study revealed an association between SLC6A4 and risperidone-induced weight gain in Chinese Han population.Semantic proximity Read ↗

Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.Semantic proximity Read ↗

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Semantic proximity Read ↗

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.Semantic proximity Read ↗

Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gainSemantic proximity Read ↗

Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.Semantic proximity Read ↗

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine.Semantic proximity Read ↗

GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine.Semantic proximity Read ↗

Genetics of antipsychotic-induced weight gain: update and current perspectives.Semantic proximity Read ↗

Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.Semantic proximity Read ↗

Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.